Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele
✍ Scribed by Cook, David G. (author);Leverenz, James B. (author);McMillan, Pamela J. (author);Kulstad, J. Jacob (author);Ericksen, Sasha (author);Roth, Richard A. (author);Schellenberg, Gerard D. (author);Jin, Lee Way (author);Kovacina, Kristina S. (author);Craft, Suzanne (author)
- Book ID
- 117021875
- Publisher
- American Society for Investigative Pathology Inc.
- Year
- 2003
- Tongue
- English
- Weight
- 370 KB
- Volume
- 162
- Category
- Article
- ISSN
- 0002-9440
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
It was suggested that in contrast to the E4 allele, the E2 allele of the apolipoprotein E gene (APOE"2) has a protective effect for late-onset Alzheimer's disease and early-onset Alzheimer's disease (EOAD). We studied the role of the APOE\*2 allele in the pathogenesis of EOAD in a Dutch population-b
A strong association has been described in cross-sectional studies between the ~4 allele of the apolipoprotein E and late-onset Alzheimer's disease (LOAD). This study addresses the relationship between disease progression and the ~4 allele in 6 2 sporadic LOAD (onset at age 70 and over) patients. Di